Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics-guided chemotherapy in elderly metastatic colorectal cancer
2006-004016-40Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Jul 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluorouracil, oxaliplatin and irinotecan in metastatic colon cancer (mCRC), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Primary endpoint: Response rate. Started Jul 2007; status: active.
02
Drugs
fluorouraciloxaliplatinirinotecan
03
Conditions
metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on 2006-004016-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004016-40.